Outcomes in Dutch DPP6 risk haplotype for familial idiopathic ventricular fibrillation: a focused update

Background The genetic risk haplotype DPP6 has been linked to familial idiopathic ventricular fibrillation (IVF), but the associated long-term outcomes are unknown. Methods DPP6 risk haplotype-positive family members ( DPP6  cases) and their risk haplotype-negative relatives ( DPP6 controls) were in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Netherlands heart journal 2023-08, Vol.31 (7-8), p.309-314
Hauptverfasser: Bergeman, Auke T., Hoeksema, Wiert F., van der Ree, Martijn H., Boersma, Lucas V. A., Yap, Sing-Chien, Verheul, Lisa M., Hassink, Rutger J., van der Crabben, Saskia N., Volders, Paul G. A., van der Werf, Christian, Wilde, Arthur A. M., Postema, Pieter G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The genetic risk haplotype DPP6 has been linked to familial idiopathic ventricular fibrillation (IVF), but the associated long-term outcomes are unknown. Methods DPP6 risk haplotype-positive family members ( DPP6  cases) and their risk haplotype-negative relatives ( DPP6 controls) were included. Clinical follow-up data were collected through March 2023. Implantable cardioverter-defibrillator (ICD) indication was divided in primary or secondary prevention. Cumulative survival and event rates were calculated. Results We included 327 DPP6  cases and 315 DPP6 controls. Median follow-up time was 9 years (interquartile range: 4–12). Of the DPP6  cases, 129 (39%) reached the composite endpoint of appropriate ICD shock, sudden cardiac arrest or death, at a median age of 45 years (range: 15–97). Median overall survival was 83 years and 87 years for DPP6  cases and DPP6 controls, respectively ( p  
ISSN:1568-5888
1876-6250
DOI:10.1007/s12471-023-01792-1